Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 91

1.

Outcome of coumarin-therapy in an outpatient setting over a 10-year period: coumarin-therapy in clinical practice.

Reininghaus EZ, Schmidt H, Lafer I, Gutjahr G, Schmidt SM, Reininghaus B, Kapfhammer HP, Stepan V.

Wien Klin Wochenschr. 2012 Nov;124(21-22):756-62. doi: 10.1007/s00508-012-0254-6. Epub 2012 Nov 6.

PMID:
23129485
2.

The duration of anticoagulation bridging therapy in clinical practice may significantly exceed that observed in clinical trials.

Deerhake JP, Merz JC, Cooper JV, Eagle KA, Fay WP.

J Thromb Thrombolysis. 2007 Apr;23(2):107-13.

PMID:
17221327
3.

Risk of major bleeding during concomitant use of antibiotic drugs and coumarin anticoagulants.

Penning-van Beest FJ, Koerselman J, Herings RM.

J Thromb Haemost. 2008 Feb;6(2):284-90. Epub 2007 Nov 20.

4.

Management and adherence to VTE treatment guidelines in a national prospective cohort study in the Canadian outpatient setting. The Recovery Study.

Kahn SR, Springmann V, Schulman S, Martineau J, Stewart JA, Komari N, McLeod A, Strulovitch C, Blostein M, Faucher JP, Gamble G, Gordon W, Kagoma PK, Miron MJ, Laverdière D, Game M, Mills A.

Thromb Haemost. 2012 Sep;108(3):493-8. doi: 10.1160/TH12-03-0169. Epub 2012 Jul 10.

PMID:
22782073
5.

Anticoagulants. Old and new.

Levi M, Eerenberg ES, Kampuisen PW.

Hamostaseologie. 2011 Nov;31(4):229-35. doi: 10.5482/ha-1153. Epub 2011 Jun 20. Review.

PMID:
21687916
6.

Periprocedural heparin bridging in patients receiving vitamin K antagonists: systematic review and meta-analysis of bleeding and thromboembolic rates.

Siegal D, Yudin J, Kaatz S, Douketis JD, Lim W, Spyropoulos AC.

Circulation. 2012 Sep 25;126(13):1630-9. Epub 2012 Aug 21. Review.

7.

Comparison of safety of subcutaneous enoxaparin as outpatient anticoagulation bridging therapy in patients with a mechanical heart valve versus patients with nonvalvular atrial fibrillation.

Bui HT, Krisnaswami A, Le CU, Chan J, Shenoy BN.

Am J Cardiol. 2009 Nov 15;104(10):1429-33. doi: 10.1016/j.amjcard.2009.06.065. Epub 2009 Sep 26.

PMID:
19892063
8.

Clinical outcomes with unfractionated heparin or low-molecular-weight heparin as bridging therapy in patients on long-term oral anticoagulants: the REGIMEN registry.

Spyropoulos AC, Turpie AG, Dunn AS, Spandorfer J, Douketis J, Jacobson A, Frost FJ; REGIMEN Investigators.

J Thromb Haemost. 2006 Jun;4(6):1246-52.

9.

Is treatment of atrial fibrillation in primary care based on thromboembolic risk assessment?

Rutten FH, Hak E, Stalman WA, Verheij TJ, Hoes AW.

Fam Pract. 2003 Feb;20(1):16-21.

10.
11.

Effect of the anticoagulant therapy in the incidence of post-thrombotic syndrome and recurrent thromboembolism: Comparative study of enoxaparin versus coumarin.

Gonz√°lez-Fajardo JA, Martin-Pedrosa M, Castrodeza J, Tamames S, Vaquero-Puerta C.

J Vasc Surg. 2008 Oct;48(4):953-9. doi: 10.1016/j.jvs.2008.05.033. Epub 2008 Jul 18.

12.

Risk factors for complications of chronic anticoagulation. A multicenter study. Warfarin Optimized Outpatient Follow-up Study Group.

Fihn SD, McDonell M, Martin D, Henikoff J, Vermes D, Kent D, White RH.

Ann Intern Med. 1993 Apr 1;118(7):511-20.

PMID:
8280198
13.

Risks of oral anticoagulant therapy with increasing age.

Torn M, Bollen WL, van der Meer FJ, van der Wall EE, Rosendaal FR.

Arch Intern Med. 2005 Jul 11;165(13):1527-32.

PMID:
16009869
14.

Intensity of anticoagulation with warfarin and risk of adverse events in patients presenting to the emergency department.

Anthony CJ, Karim S, Ackroyd-Stolarz S, Fry A, Murphy NG, Christie R, Zed PJ.

Ann Pharmacother. 2011 Jul;45(7-8):881-7. doi: 10.1345/aph.1P670. Epub 2011 Jul 12.

PMID:
21750309
15.

Bleeding rates in patients older than 90 years of age on vitamin K antagonist therapy for nonvalvular atrial fibrillation.

Tincani E, Baldini P, Crowther MA, Zanasi A, Ferrari P, Cenci AM, Rioli G.

Blood Coagul Fibrinolysis. 2009 Jan;20(1):47-51. doi: 10.1097/MBC.0b013e32831be9da.

PMID:
20523164
16.

Warfarin for non-rheumatic atrial fibrillation: five year experience in a district general hospital.

Yousef ZR, Tandy SC, Tudor V, Jishi F, Trent RJ, Watson DK, Cowell RP.

Heart. 2004 Nov;90(11):1259-62.

17.

Variations in perioperative warfarin management: outcomes and practice patterns at nine hospitals.

Jaffer AK, Brotman DJ, Bash LD, Mahmood SK, Lott B, White RH.

Am J Med. 2010 Feb;123(2):141-50. doi: 10.1016/j.amjmed.2009.09.017.

PMID:
20103023
18.

Concomitant coumarin-NSAID therapy and risk for bleeding.

Knijff-Dutmer EA, Schut GA, van de Laar MA.

Ann Pharmacother. 2003 Jan;37(1):12-6.

PMID:
12503926
19.

Emergency reversal of anticoagulation: the real use of prothrombin complex concentrates: a prospective multicenter two year French study from 2006 to 2008.

Desmettre T, Dubart AE, Capellier G, Fanara B, Puyraveau M, Kepka S, Coquart J, Sheppard F, Tazarourte K.

Thromb Res. 2012 Sep;130(3):e178-83. doi: 10.1016/j.thromres.2012.05.029. Epub 2012 Jun 21.

PMID:
22726885
20.

Incidence of thromboembolic complications in patients with atrial fibrillation or mechanical heart valves with a subtherapeutic international normalized ratio: a prospective multicenter cohort study.

Dentali F, Pignatelli P, Malato A, Poli D, Di Minno MN, Di Gennaro L, Rancan E, Pastori D, Grifoni E, Squizzato A, Siragusa S, Di Minno G, Ageno W.

Am J Hematol. 2012 Apr;87(4):384-7. doi: 10.1002/ajh.23119. Epub 2012 Feb 24. Erratum in: Am J Hematol. 2012 Jul;87(7):748. Grifoni, Elena [corrected to Grifoni, Elisa].

Items per page

Supplemental Content

Write to the Help Desk